Latest tumor Stories
Program Funded by the National Cancer Institute (NCI) CHARLOTTESVILLE, Va., Oct.
LEWISVILLE, Texas and CLEVELAND, Oct.
Results, Published in Clinical Genitourinary Cancer, Offer Key Insights and Potential New Treatment Strategies for Patient Population with Limited Drug Options IRVING, Texas, Oct.
Completion of Enrollment Expected in 2015; Progression-Free Survival Data Expected in mid-2016 LOS ANGELES, Sept.
- Awarded phase II STTR grant of approximately $1.1 million from NIH to develop tumor activated prodrugs BOSTON, Sept.
ALBANY, New York, September 29, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Circulating Circulating Tumor Cells (CTCs)
Additional Study Focuses on the Detection and Quantitative Monitoring of EGFR Mutations in Lung Cancer Patients SAN DIEGO, Sept.
Medical journey of Arizona boy precedes that of Britain's Ashya King SAN DIEGO, Sept.
LOS ANGELES, Sept.
-- PEG-Irinotecan is a novel, long-acting polymer-drug conjugate which inhibits Topo-I associated with solid tumors SHENYANG, China, Sept.
- A bereavement by loss of parents or children; the state of being orbate; orbation.